ETF Analysis
XLV ETF: Healthcare Holdings, Performance and Sector Exposure
XLV answer
XLV, the Health Care Select Sector SPDR Fund, holds the 63 health care companies in the S&P 500: drugmakers, insurers, device makers and service providers. Its largest positions are LLY (14.9%), JNJ (10.7%), ABBV (7.5%), MRK (6.0%), UNH (5.9%), and the top ten make up 60.9% of the fund. XLV's expense ratio is 0.08%, and over the past year its price return was +24.2%.
- Expense ratio
- 0.08%
- Fund size
- $47.02B
- Holdings
- 63
- Top 10 weight
- 60.9%
- 1Y price return
- +24.2%
State Street Health Care Select Sector SPDR ETF (XLV) currently has an AIQ Score of 60/100, indicating a neutral setup. Momentum is the strongest factor at 82/100. Value is the weakest current factor at 31/100. Performance, momentum, risk, distribution, and exposure evidence should be read together at the latest market-close snapshot.
XLV at a Glance
Crawlable current metrics from the latest market-close ETF snapshot.
| Metric | Current |
|---|---|
| Price | $178.94 |
| AIQ Score | 60/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Fund Size | $47.02B |
| Expense Ratio | 0.08% |
| Holdings Count | 63 |
| NAV | $175.60 |
| Asset Class | Equity |
| Primary Exposure | Healthcare (99.08%) |
| Issuer | SPDR |
| Domicile | US |
| Inception Date | Dec 16, 1998 |
| Distribution Yield | 1.45% |
| Beta | 0.56 |
| Average Volume | 9.08M |
| 52-week range | $141.97-$180.06 |
| RSI 14 | 76.39 |
| 50-Day SMA | $170.64 |
| 200-Day SMA | $157.86 |
| Risk Score | 62/100 |
| Momentum Score | 82/100 |
| Value Exposure Score | 31/100 |
XLV Long-Horizon ETF Performance
Trailing returns, growth of $10,000, drawdown history, and calendar-year returns from available daily closes.
| Period | Total return | Annualized | Max drawdown | Start date |
|---|---|---|---|---|
| 1Y | 24.19% | 24.21% | -10.84% | Oct 20, 2025 |
| 3Y | 40.42% | 11.98% | -18.11% | Oct 20, 2023 |
| 5Y | 36.57% | 6.44% | -18.11% | Oct 22, 2021 |
| 10Y | 36.57% | 6.44% | -18.11% | Oct 22, 2021 |
Growth of $10,000
Indexed to the first available close in this history window.
Drawdown History
Peak-to-trough decline from each prior high over the available window.
Calendar-Year Returns
Full-year returns where available, with the current calendar year shown as YTD.
XLVState Street Health Care Select Sector SPDR ETF
Financial Services / Asset Management
Low Priority
Above Peers
Latest quote
- Momentum82
- Value31
- Quality70
- Risk resilience62
- Sentiment—
XLV ETF Analysis Summary
State Street Health Care Select Sector SPDR ETF (XLV) currently has an AIQ Score of 60/100, indicating a neutral setup. Momentum is the strongest factor at 82/100. Value is the weakest current factor at 31/100. Performance, exposure, distribution, momentum, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, XLV has AIQ Score of 60/100 with Momentum base of 82/100 and fading Value at 31/100. Wait for component alignment before adding exposure.
Momentum (82/100) leads while Value (31/100) lags. This cross-factor spread creates entry timing uncertainty.
Financial Services · -0.49% ETF move · XLV classified in Asset Management.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is XLV Bullish or Bearish Right Now?
XLV currently has a neutral overall setup. Momentum is the strongest factor at 82/100, while Value is weakest at 31/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 70/100.
- - Momentum is constructive at 82/100.
- - Risk Resilience is supportive at 62/100.
- - Price is +4.86% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (37 vs 7).
- - Value is the current constraint at 31/100.
Current Consensus
XLV's Technical Analysis Consensus is currently Strong Buy, with 37 buy, 1 neutral, and 7 sell votes. XLV's 14-day RSI is 76.39, which places the ETF in an overbought momentum range. XLV's beta is 0.56, indicating lower market sensitivity than the broad market.
What Changed in XLV?
The largest recent change in XLV is Momentum moving up by 11.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the XLV Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, risk resilience improves, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, distribution or liquidity context deteriorates, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive market-context evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
XLV Decision Framework
Public evidence layers, setup checks, and risk context for State Street Health Care Select Sector SPDR ETF.
State Street Health Care Select Sector SPDR ETF (XLV) ETF Analysis
State Street Health Care Select Sector SPDR ETF has an AIQ Score of 60/100 in a Neutral regime. Momentum is strongest at 82/100. Beta is 0.56, below market sensitivity. Review the supporting etf factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | XLV is in a Neutral AIQ regime with score 60/100. |
| Signal Conflict | The primary conflict is that momentum leads at 82/100 while value lags at 31/100. |
| Factor Evidence | Momentum 82/100 · Value 31/100 · Quality 70/100 · Risk 62/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 82/100.
Momentum is 82/100 and RSI (14) is 76.4.
XLV is in a Neutral regime at 60/100.
Risk factor is 62/100 with beta 0.56 and annual volatility 16.22%.
Current conflict: momentum leads at 82/100 while value lags at 31/100.
XLV Research Cluster
ETF-specific paths for performance, risk, distributions, market context, data, comparisons, and news.
XLV ETF Analytics
XLV holdings context, yield, risk, valuation exposure, momentum, and AIQ evidence.
XLV Technical Analysis
XLV technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
XLV ETF Market Context
Track XLV market context, news pressure, trend changes, income events, and current allocation evidence.
XLV Distribution Analysis
XLV distribution yield, annualized distributions, payment history, and income context.
XLV ETF Data
XLV available fund data, market metrics, technical readings, risk measures, and AIQ evidence.
XLV Risk Analysis
XLV volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
XLV ETF News
XLV ETF news, market tone, recent headlines, and catalyst context.
XLV vs ETF Peers
Current peer cohort: XLV · LLY · UNH · JNJ · ABBV. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| XLV Current ETF | 60/100 | 31/100 | 82/100 | 62/100 | 1.15 | 16.22% | Current |
| LLY Eli Lilly | 62/100 | 26/100 | 95/100 | 50/100 | 1.36 | 34.89% | XLV vs LLY |
| UNH UnitedHealth Group | 63/100 | 59/100 | 95/100 | 51/100 | 0.46 | 34.82% | XLV vs UNH |
| JNJ Johnson & Johnson | 52/100 | 39/100 | 48/100 | 48/100 | 1.31 | 20.43% | XLV vs JNJ |
| ABBV AbbVie | 56/100 | 36/100 | 82/100 | 44/100 | 0.77 | 25.89% | XLV vs ABBV |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 21, 2026.
Popular XLV Comparisons
How XLV scores against the names it is most often compared with.
About the AIQ Score
Methodology for the current ETF evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of ETF evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Valuation exposure across the fund's holdings.
Quality context inferred from fund exposure and available evidence.
Trend, momentum, volume, and timing confirmation.
Resilience, volatility, beta, drawdown, and tail risk.
News and event pressure around the setup.
Open the return calculator with ETF context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalystsNo quarterly financial rows in this snapshot.
Checked Oct 21, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
ETF Analytics Snapshot
Current ETF evidence uses fund profile, cost, size, distribution, momentum, and risk fields.
ETF pages use fund-native profile fields for cost, size, liquidity, holdings breadth, NAV, issuer, and launch date.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching XLV
Open the detailed evidence pages and workflows behind the ETF overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for XLV
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
XLV ETF FAQ
What are XLV's top holdings?
XLV's largest positions are LLY (14.9%), JNJ (10.7%), ABBV (7.5%), MRK (6.0%), UNH (5.9%).
What is XLV's expense ratio?
XLV's expense ratio is 0.08% a year.